PHARMACOLOGICAL APPROACHES IN CELL DYSFUNCTION (MOD. 4: PHARMACOLOGICAL APPROACHES OF THE UNFOLDED PROTEIN RESPONSE)
PHARMACOLOGICAL APPROACHES IN CELL DYSFUNCTION (MOD. 4: PHARMACOLOGICAL APPROACHES OF THE UNFOLDED PROTEIN RESPONSE)
A.Y. | Credits |
---|---|
2024/2025 | 1 |
Lecturer | Office hours for students | |
---|---|---|
Ester Zito | Every Wednsday at 1 pm |
Teaching in foreign languages |
---|
Course entirely taught in a foreign language
English
This course is entirely taught in a foreign language and the final exam can be taken in the foreign language. |
Assigned to the Degree Course
Date | Time | Classroom / Location |
---|
Date | Time | Classroom / Location |
---|
Learning Objectives
By the end of the course, the student will be able to:
Understand the molecular mechanisms of the Unfolded Protein Response (UPR), with particular focus on the three main signaling pathways (IRE1, PERK, and ATF6) and their role in maintaining endoplasmic reticulum homeostasis.
Critically analyze the main pharmacological approaches for modulating the UPR, distinguishing between inhibitors and activators specific to the different branches of the pathway.
Evaluate the therapeutic potential of pharmacologically targeting the UPR in relevant diseases such as neurodegenerative disorders, cancer, and metabolic diseases.
Interpret experimental data from preclinical and clinical studies on UPR-targeting compounds, with particular attention to side effects and the specificity of pharmacological interventions.
Program
I. Introduction to the UPR and Biological Context
Function of the endoplasmic reticulum (ER) and causes of ER stress
Activation and roles of the three UPR signaling pathways:
IRE1 (inositol-requiring enzyme 1)
PERK (PKR-like ER kinase)
ATF6 (activating transcription factor 6)
Role of the UPR in cellular homeostasis and cell fate decisions
II. Pharmacological Targets within the UPR
Rationale for pharmacological modulation of the UPR
"Pro-survival" vs. "Pro-apoptotic" strategies
Examples of pharmacological targets:
PERK inhibitors/activators (e.g., GSK2606414, ISRIB)
RNase inhibitors of IRE1α (e.g., MKC-3946)
ATF6 modulators (e.g., Ceapin-A7)
III. Preclinical Studies and Therapeutic Applications
UPR and cancer: how certain tumor cells exploit the UPR for survival
Neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s)
Metabolic diseases (e.g., diabetes, hepatic steatosis)
Overview of compounds in preclinical and clinical development
IV. Case Study and Scientific Article Analysis
Examples: one study on ERO1A in cancer and application of its inhibitors, another on ERO1 in muscular diseases and application of chemical chaperone such as TUDCA
Analysis of experimental strategies, results, and therapeutic implications
V. Discussion and Conclusions
Future perspectives and current challenges in pharmacological modulation of the UPR
Bridging Courses
NA
Learning Achievements (Dublin Descriptors)
Knowledge and Understanding
The PhD student will acquire an advanced and critical understanding of the molecular mechanisms of the UPR and of the main pharmacological approaches developed to modulate it, including their relevance to complex diseases.
Applying Knowledge and Understanding
The student will be able to apply this knowledge to the analysis of scientific experiments, the design of research hypotheses, and the evaluation of the effectiveness of pharmacological compounds in cellular or animal models.
Making Judgements
The student will develop critical skills in evaluating scientific literature and preclinical/clinical data related to UPR modulation, also in the context of identifying new therapeutic targets.
Communication Skills
The student will be able to clearly and rigorously discuss UPR-related pharmacological strategies with the scientific community, using appropriate terminology and up-to-date literature.
Learning Skills
The course will stimulate the ability to independently learn about new developments in the field of cellular and molecular pharmacology, enabling the student to stay continuously informed about emerging technologies and innovative therapeutic approaches.
Teaching Material
The teaching material prepared by the lecturer in addition to recommended textbooks (such as for instance slides, lecture notes, exercises, bibliography) and communications from the lecturer specific to the course can be found inside the Moodle platform › blended.uniurb.it
Supporting Activities
NA
Teaching, Attendance, Course Books and Assessment
- Teaching
The course will be structured using an active and participatory teaching approach, designed to promote critical learning and the integration of theory with research. The planned methods include:
Interactive lecture (with multimedia support):
Presentation of fundamental concepts, the molecular pathways involved in the UPR, and the main pharmacological approaches. Throughout the lecture, questions and brief discussion moments will be encouraged to foster active reflection.
- Attendance
NA
- Course books
NA
- Assessment
NA
- Disability and Specific Learning Disorders (SLD)
Students who have registered their disability certification or SLD certification with the Inclusion and Right to Study Office can request to use conceptual maps (for keywords) during exams.
To this end, it is necessary to send the maps, two weeks before the exam date, to the course instructor, who will verify their compliance with the university guidelines and may request modifications.
Additional Information for Non-Attending Students
- Teaching
The course will be structured using an active and participatory teaching approach, designed to promote critical learning and the integration of theory with research. The planned methods include:
Interactive lecture (with multimedia support):
Presentation of fundamental concepts, the molecular pathways involved in the UPR, and the main pharmacological approaches. Throughout the lecture, questions and brief discussion moments will be encouraged to foster active reflection.
- Attendance
NA
- Course books
NA
- Assessment
NA
- Disability and Specific Learning Disorders (SLD)
Students who have registered their disability certification or SLD certification with the Inclusion and Right to Study Office can request to use conceptual maps (for keywords) during exams.
To this end, it is necessary to send the maps, two weeks before the exam date, to the course instructor, who will verify their compliance with the university guidelines and may request modifications.
« back | Last update: 11/05/2025 |